From secrecy and skepticism to one of the fastest vaccine rollouts in history, this episode of Petri Dish Perspectives: Biotech Unleashed dives into the remarkable journey of Moderna. We trace the company’s early hype, billion-dollar p...

Baxter may not always grab the biotech headlines, but its impact on modern healthcare is impossible to ignore. From the first commercially prepared IV solutions in the 1930s to pioneering dialysis fluids, blood systems, recombinant hemophilia t...

In this episode of Petri Dish Perspectives: Biotech Unleashed, host Manead explores the remarkable journey of AstraZeneca, from its unlikely Swedish-British merger to blockbuster drugs like Nexium and Crestor, through near-decli...

In this episode of Petri Dish Perspectives: Biotech Unleashed, we dive into the remarkable and controversial story of Gilead Sciences, a company that redefined what medicine could achieve. From its beginnings in the late 1980s u...

In this episode of Petri Dish Perspectives: Biotech Unleashed, we dive into the story of GlaxoSmithKline (GSK), one of the world’s most influential pharma giants!From scaling up penicillin production in WWII, to pioneering semi-...

In this episode of Petri Dish Perspectives: Biotech Unleashed, we dive deep into the origin story of Amgen, a company that helped turn “biotechnology” from a niche lab concept into a global medical force.We’ll trace Amgen...

What happens when one of the world’s most powerful genomics companies rises from a college dorm in China and goes on to challenge the West’s biotech dominance? In this episode of Petri Dish Perspectives: Biotech Unleashed, we unravel t...

In this episode of Petri Dish Perspectives: Biotech Unleashed, host Manead takes you inside the remarkable story of Abbott Laboratories: a company that doesn’t chase headlines but touches billions of lives every day.From its ori...

DISCLAIMER: This is a consistently changing situation. The episode was recorded approximately 4 PM EDT Monday, July 21, 2025.  As of 7.40 PM EDT Monday, July 21, 2025 (Source: Sarepta), "Sarepta Therapeutics notified the U.S. FDA of its...

🔬✨ From Cystic Fibrosis Breakthroughs to Gene Editing CuresIn this episode of Petri Dish Perspectives: Biotech Unleashed, Manead unpacks how Vertex turned cystic fibrosis from a fatal disease into a treatable condition an...

🧬 From VC to Blockbusters: The Genentech Story In Episode 11 of Petri Dish Perspectives: Biotech Unleashed, host Manead dives into the legendary rise of Genentech, the startup that sparked the biotech revolution. From its hu...

💡 From Vitamin C to AI-Driven Diagnostics: Roche’s Legacy Unleashed In this episode of Petri Dish Perspectives: Biotech Unleashed, we explore the extraordinary evolution of Roche, from its origins as a 19th-century Swiss che...

🎧 From Dye Pots to Blockbusters: The Bayer Story In this episode of Petri Dish Perspectives: Biotech Unleashed, host Manead takes you on a journey through Bayer’s 160+ year evolution, from its 1863 roots in coal tar dyes to ...

In this episode of Petri Dish Perspectives: Biotech Unleashed, we journey through the 165+ year saga of Bristol Myers Squibb (BMS) — from 19th-century Brooklyn apothecaries and sparkling laxatives 💊 to cutting-edge CAR...

Ever wonder how an oil conglomerate helped create one of the world’s top pharma giants? 💥 In this episode of Petri Dish Perspectives: Biotech Unleashed, your host, Manead, dives into the fascinating story of Sanofi, a company wh...

In this episode of Petri Dish Perspectives: Biotech Unleashed, we'll take you on a 350-year journey through the rise of Merck — from its humble beginnings as a family-run pharmacy in 17th-century Germany to becoming one of the world’s ...

🐴 From Farmyard Roots to Pharma Powerhouse: The Boehringer Ingelheim Story 🐴Welcome to Petri Dish Perspectives: Biotech Unleashed! 🚀 I’m your host, Manead—scientist and biotech nerd.Today, we’re spotlighting Boehringer Ingelheim—a...

In this episode of Petri Dish Perspectives: Biotech Unleashed, we dive into the rich history and groundbreaking innovations of Johnson & Johnson (J&J)—one of the most influential healthcare companies in the world. From i...

In this episode of Petri Dish Perspectives: Biotech Unleashed, we explore the rise of AbbVie, a pharmaceutical giant that emerged from Abbott Laboratories in 2013 and quickly became a leader in immunology, oncology, and aestheti...

Welcome to Petri Dish Perspectives: Biotech Unleashed! In this episode, we dive deep into the history and impact of Eli Lilly, a company that began with a small lab in Indianapolis and has grown into the highest market-cap ph...

💊 From Brooklyn to Biotech Titan: The Rise of Pfizer 💊Welcome to the first-ever episode of Petri Dish Perspectives: Biotech Unleashed! 🚀 I’m your host, Manead—scientist, biotech nerd, and your guide through the fas...